V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310007157 | 310004324 | null | 89 | Curative (C) | 2013-09-22 | 2013-09-24 | Brentuximab | 2 | N | 310016303 | BRENTUXIMAB |
| 310007158 | 310007807 | 1.58 | 50 | Curative (C) | 2018-07-23 | 2018-07-24 | IVE | 1 | N | 310016307 | IVE |
| 310007159 | 310007807 | null | 70.2 | Palliative (P) | 2015-07-18 | 2015-07-27 | PEMBROLIZUMAB | N | null | 310016307 | PEMBROLIZUMAB |
| 310007160 | 310010661 | 0 | 50.6 | Curative (C) | 2018-02-02 | 2018-02-07 | EW EuroEwing 2012 Arm B VC | Y | N | 310016322 | NOT MATCHED |
| 310007163 | 310004329 | 1.62 | 77.9 | Curative (C) | 2015-12-21 | 2015-12-30 | IVE | N | N | 310016356 | IVE |
| 310007164 | 310004330 | null | 51.7 | Disease modification (D) | 2015-09-20 | 2015-09-27 | null | 02 | N | 310016356 | NOT MATCHED |
| 310007165 | 310009669 | 1.73 | 65.8 | null | 2014-04-03 | 2014-04-03 | GEMCITABINE | 02 | N | 310016377 | GEMCITABINE |
| 310007166 | 310004334 | 1.54 | 89.1 | Palliative (P) | 2018-03-16 | 2018-03-28 | PEMBROLIZUMAB | 2 | N | 310016379 | PEMBROLIZUMAB |
| 310007167 | 310004334 | 1.64 | 62.5 | Palliative (P) | 2017-11-03 | 2017-11-26 | Brentuximab | N | N | 310016379 | BRENTUXIMAB |
| 310007168 | 310009670 | 1.62 | 21.2 | Not known (9) | 2014-01-15 | 2014-01-15 | Gemcitabine + Methylprednisolone | 02 | N | 310016401 | GEMCITABINE |
| 310007169 | 310004335 | 1.62 | 53 | Palliative (P) | 2017-01-26 | 2017-01-26 | GEM-P | N | N | 310016402 | GEMCITABINE + PACLITAXEL |
| 310007170 | 310007812 | 1.48 | 13 | Palliative (P) | 2018-04-04 | 2018-04-06 | BEAM | 02 | N | 310016430 | BEAM |
| 310007171 | 310004336 | 1.8 | null | Curative (C) | 2013-11-05 | 2014-09-17 | BEAM | 2 | N | 310016438 | BEAM |
| 310007172 | 310007813 | 1.58 | 62 | Curative (C) | 2015-09-02 | 2015-10-17 | BEAM | N | N | 310016458 | BEAM |
| 310007173 | 310004337 | 1.7 | 57.9 | Palliative (P) | 2015-11-06 | 2015-11-06 | Gemcitabine weekly | 2 | N | 310016471 | GEMCITABINE |
| 310007175 | 310004342 | 1.63 | 89.2 | Palliative (P) | null | 2018-08-16 | GEM-P | 2 | null | 310016481 | GEMCITABINE + PACLITAXEL |
| 310007176 | 310004342 | 1.68 | 100.6 | Palliative (P) | 2017-04-23 | 2017-04-23 | PEMBROLIZUMAB | 2 | N | 310016481 | PEMBROLIZUMAB |
| 310007177 | 310004342 | 1.75 | 55.2 | Disease modification (D) | 2014-02-02 | 2014-08-30 | BMT | 02 | N | 310016481 | NOT MATCHED |
| 310007178 | 310004342 | 1.7 | null | Not known (9) | 2017-07-23 | 2018-11-06 | LEAM | 2 | N | 310016481 | LEAM |
| 310007179 | 310004343 | 1.74 | null | Palliative (P) | null | 2014-07-15 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 310016521 | GEMCITABINE |
| 310007180 | 310004343 | 1.5 | 92 | Curative (C) | 2017-11-30 | 2018-01-23 | BEAM | N | N | 310016521 | BEAM |
| 310007181 | 310004343 | 1.77 | 72.4 | Palliative (P) | 2017-07-13 | 2017-07-16 | LEAM | Y | N | 310016521 | LEAM |
| 310007182 | 310004343 | 1.78 | 67.3 | Curative (C) | 2016-01-15 | 2016-01-16 | LEAM | Y | N | 310016521 | LEAM |
| 310007183 | 310004343 | 1.45 | 57 | Palliative (P) | 2018-05-03 | 2018-05-10 | PEMBROLIZUMAB | N | N | 310016521 | PEMBROLIZUMAB |
| 310007184 | 310004343 | 1.83 | 93.3 | Palliative (P) | 2017-10-22 | 2018-03-11 | Gemcitabine + Paclitaxel | N | N | 310016521 | GEMCITABINE + PACLITAXEL |
| 310007185 | 310004343 | 1.71 | 60.5 | Palliative (P) | 2016-02-12 | 2016-02-23 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 310016521 | CISPLATIN + GEMCITABINE |
| 310007186 | 310004343 | 0 | 69.6 | Curative (C) | 2016-10-28 | 2016-11-22 | ROMICAR Trial | N | N | 310016521 | NOT MATCHED |
| 310007187 | 310004344 | 1.88 | 97.1 | Palliative (P) | 2016-12-17 | 2016-12-19 | Carboplatin + Liposomal Doxorubicin | N | N | 310016601 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007188 | 310004345 | 0 | 90.3 | Palliative (P) | 2015-05-28 | 2015-06-10 | Carboplatin + Liposomal Doxorubicin | Y | N | 310016629 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007189 | 310004348 | 1.72 | 104 | Palliative (P) | 2017-04-03 | 2017-04-04 | PEMBROLIZUMAB | 02 | N | 310016630 | PEMBROLIZUMAB |
| 310007190 | 310004349 | null | null | Palliative (P) | 2017-10-12 | 2017-10-15 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 310016631 | GEMCITABINE |
| 310007191 | 310004350 | 1.8 | 92.7 | Curative (C) | 2016-05-16 | 2016-08-22 | IVE | 2 | N | 310016633 | IVE |
| 310007192 | 310010664 | 1.89 | null | Palliative (P) | 2017-04-23 | 2017-04-23 | PEMBROLIZUMAB | N | N | 310016633 | PEMBROLIZUMAB |
| 310007193 | 310004351 | 1.57 | 72.2 | Curative (C) | 2015-11-04 | 2015-11-19 | IVE | N | N | 310016650 | IVE |
| 310007194 | 310004352 | 1.19 | 53.3 | Palliative (P) | 2017-05-28 | 2017-05-29 | null | N | N | 310016659 | NOT MATCHED |
| 310007195 | 310004353 | 0 | 132.8 | Curative (C) | 2017-10-29 | 2017-11-04 | ETOPOSIDE + GEMCITABINE + IFOSFAMIDE | null | null | 310016669 | NOT MATCHED |
| 310007196 | 310004355 | 1.78 | 64.5 | Palliative (P) | 2015-08-30 | 2015-09-01 | BEAM | N | N | 310016672 | BEAM |
| 310007197 | 310004357 | 1.68 | 70 | Curative (C) | 2014-07-25 | 2014-08-15 | IVE | 2 | N | 310016672 | IVE |
| 310007198 | 310004357 | 1.68 | null | Not known (9) | 2018-01-20 | 2018-01-30 | PEMBROLIZUMAB | 02 | null | 310016672 | PEMBROLIZUMAB |
| 310007199 | 310004357 | 1.85 | 98 | Curative (C) | null | 2015-12-21 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | 310016672 | CISPLATIN + GEMCITABINE |
| 310007200 | 310011721 | 1.66 | 54 | null | null | 2017-07-08 | LEAM | N | Y | 310016722 | LEAM |
| 310007201 | 310004358 | 1.76 | 79.7 | Disease modification (D) | 2013-12-31 | 2014-01-11 | Mini BEAM | N | null | 310016746 | BEAM |
| 310007202 | 310004358 | 1.67 | 63 | Neo-adjuvant (N) | 2018-10-29 | 2018-11-05 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310016746 | CISPLATIN + GEMCITABINE |
| 310007203 | 310004358 | 1.89 | 77 | Palliative (P) | 2015-05-06 | 2015-05-07 | Brentuximab | 2 | N | 310016746 | BRENTUXIMAB |
| 310007204 | 310004358 | null | 69.6 | Palliative (P) | 2017-01-18 | 2017-01-21 | Carboplatin + Liposomal Doxorubicin | N | N | 310016746 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007205 | 310004358 | 1.62 | 87 | Palliative (P) | null | 2017-03-07 | GEMCITABINE | N | N | 310016746 | GEMCITABINE |
| 310007206 | 310004358 | 1.69 | 66 | Disease modification (D) | 2013-09-16 | 2013-09-24 | BEAM | N | N | 310016746 | BEAM |
| 310007207 | 310004358 | 1.68 | 85 | Curative (C) | null | 2017-08-20 | LEAM | 02 | N | 310016746 | LEAM |
| 310007208 | 310004360 | 1.66 | 85 | Palliative (P) | 2016-05-12 | 2016-08-08 | Carboplatin + Liposomal Doxorubicin | N | N | 310016795 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007209 | 310007825 | 1.57 | 69 | Palliative (P) | 2017-09-22 | 2018-07-01 | CARBOPLATIN + LIPOSOMAL DOX | N | N | 310016795 | CARBOPLATIN + LIPOSOMAL DOX |